China National Medicines Corp Ltd (600511) — Free Cash Flow Generation Index
China National Medicines Corp Ltd (600511) has a Free Cash Flow Generation Index of 0.97x as of June 2025. Free cash flow of CN¥369.51 Million represents 1% of operating cash flow (CN¥382.74 Million). See China National Medicines Corp Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China National Medicines Corp Ltd Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for China National Medicines Corp Ltd across 22 annual periods. Explore debt repayment capacity of China National Medicines Corp Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for China National Medicines Corp Ltd (2002–2024)
Year-by-year Free Cash Flow Generation Index for China National Medicines Corp Ltd. For the full company profile including market capitalisation, see China National Medicines Corp Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.92x | CN¥1.53 Billion | CN¥1.66 Billion | CN¥130.77 Million | ▼ -2.7% |
| 2023 | 0.95x | CN¥2.58 Billion | CN¥2.73 Billion | CN¥145.12 Million | ▲ +0.1% |
| 2022 | 0.95x | CN¥2.27 Billion | CN¥2.40 Billion | CN¥129.78 Million | ▼ -0.6% |
| 2021 | 0.95x | CN¥1.86 Billion | CN¥1.96 Billion | CN¥95.07 Million | ▲ +0.5% |
| 2020 | 0.95x | CN¥1.23 Billion | CN¥1.30 Billion | CN¥69.05 Million | ▼ -0.5% |
| 2019 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | CN¥85.72 Million | ▲ +10.0% |
| 2018 | 0.87x | CN¥849.19 Million | CN¥981.65 Million | CN¥132.46 Million | ▼ -7.2% |
| 2017 | 0.93x | CN¥1.00 Billion | CN¥1.07 Billion | CN¥73.25 Million | ▼ -0.1% |
| 2016 | 0.93x | CN¥551.38 Million | CN¥591.25 Million | CN¥39.88 Million | ▲ +10.4% |
| 2015 | 0.84x | CN¥371.82 Million | CN¥440.29 Million | CN¥68.47 Million | ▲ +161.5% |
| 2014 | 0.32x | CN¥70.72 Million | CN¥218.94 Million | CN¥148.22 Million | ▼ -6.2% |
| 2013 | 0.34x | CN¥63.91 Million | CN¥185.56 Million | CN¥121.66 Million | ▲ +294.7% |
| 2012 | 0.09x | CN¥16.22 Million | CN¥185.87 Million | CN¥169.65 Million | ▼ -90.6% |
| 2010 | 0.92x | CN¥294.12 Million | CN¥318.21 Million | CN¥24.09 Million | ▲ +1.3% |
| 2009 | 0.91x | CN¥232.85 Million | CN¥255.18 Million | CN¥22.33 Million | ▼ -1.4% |
| 2008 | 0.93x | CN¥200.89 Million | CN¥217.10 Million | CN¥16.21 Million | ▲ +3.8% |
| 2007 | 0.89x | CN¥70.86 Million | CN¥79.48 Million | CN¥8.61 Million | ▲ +10.9% |
| 2006 | 0.80x | CN¥97.69 Million | CN¥121.50 Million | CN¥23.81 Million | ▲ +45.5% |
| 2005 | 0.55x | CN¥50.96 Million | CN¥92.20 Million | CN¥41.24 Million | ▲ +171.7% |
| 2004 | -0.77x | CN¥-37.90 Million | CN¥49.18 Million | CN¥87.08 Million | ▲ +99.6% |
| 2003 | -171.79x | CN¥-90.39 Million | CN¥526.15K | CN¥90.92 Million | ▼ -260133.2% |
| 2002 | 0.07x | CN¥1.00 Million | CN¥15.19 Million | CN¥14.19 Million | — |